Abstract
Purpose
Previous studies in our laboratory have suggested that GHB may undergo renal reabsorption mediated by monocarboxylic acid transporters (MCT). The objectives of this study were to characterize the renal transport of GHB using HK-2 cells and the role of MCT in the renal transport of GHB.
Materials and Methods
Western blot was used to detect the protein expression of MCT1, 2, and 4. Cellular uptake and directional flux studies were conducted to investigate the transport of GHB and L-lactate. RNA interference assay was used to investigate the involvement of MCT isoforms in the transport of GHB.
Results
MCT1, 2 and 4 were present in HK-2 cells. The cellular uptake of L-lactate and GHB exhibited pH- and concentration-dependence (L-lactate: K m of 6.5 ± 1.1 mM and V max of 340 ± 60 nmol mg−1min−1; GHB: K m of 2.07 ± 0.79 mM, V max of 27.6 ± 9.3 nmol mg−1min−1, and a diffusional clearance of 0.54 ± 0.15 μl mg−1min−1), but not sodium-dependence. α-Cyano-4-hydroxycinnamate (CHC) competitively inhibited the uptake of GHB and L-lactate with inhibition constants (K i) of 0.28 ± 0.1 mM, and 0.19 ± 0.03 mM, respectively. Using small-interference RNA (siRNA) for MCT1, the protein expression of MCT1 and the uptake of L-lactate and GHB were significantly decreased. The siRNA treatment of MCT2 in HK-2 cells inhibited the uptake of GHB by 17%, and the siRNA treatment of MCT4 demonstrated no inhibition of GHB uptake. GHB exhibited a directional flux across HK-2 monolayer from apical to basal chambers in the presence of a pH gradient of pH 6.0 to pH 7.4.
Conclusion
These data suggest that MCT1 represents an important transporter for GHB transport in renal tubule cells, responsible for the reabsorption of GHB in the kidney.
Similar content being viewed by others
Abbreviations
- CHC:
-
α-cyano-4-hydroxycinnamate
- DIDS:
-
4,4′-diisothiocyanatostilbene-2,2′-disulphonic acid
- GHB:
-
γ-hydroxybutyrate
- MCT:
-
monocarboxylate transporter
- PCMB:
-
p-chloro-mercuribenzoic acid
- TEA:
-
tetraethylammonium chloride
- SiRNA:
-
small interference RNA
References
R. H. Roth and N. J. Giarman. Natural occurrence of gamma-hydroxybutyrate in mammalian brain. Biochem. Pharmacol. 19:1087–1093 (1970).
S. P. Bessman and W. N. Fishbein. Gamma-hydroxybutyrate, a normal brain metabolite. Nature 200:1207–1208 (1963).
M. Maitre. The gamma-hydroxybutyrate signalling system in brain: organization and functional implications. Prog. Neurobiol. 51:337–361 (1997).
M. Mamelak, M. B. Scharf, and M. Woods. Treatment of narcolepsy with gamma-hydroxybutyrate. A review of clinical and sleep laboratory findings. Sleep 9:285–289 (1986).
L. Gallimberti, M. R. Spella, C. A. Soncini, and G. L. Gessa. Gamma-hydroxybutyric acid in the treatment of alcohol and heroin dependence. Alcohol 20:257–262 (2000).
M. S. Okun, L. A. Boothby, R. B. Bartfield, and P. L. Doering. GHB: an important pharmacologic and clinical update. J. Pharm. Sci. 4:167–175 (2001).
C. G. Wong, K. M. Gibson, and O. C. Snead, 3rd. From the street to the brain: neurobiology of the recreational drug gamma-hydroxybutyric acid. Trends Pharmacol. Sci. 25:29–34 (2004).
P. E. Masonand and W. P. Kerns, 2nd. Gamma hydroxybutyric acid (GHB) intoxication. Acad. Emerg. Med. 9:730–739 (2002).
J. Lettieri and H. L. Fung. Improved pharmacological activity via pro-drug modification: comparative pharmacokinetics of sodium gamma-hydroxybutyrate and gamma-butyrolactone. Res. Commun. Chem. Pathol. Pharmacol. 22:107–118 (1978).
J. T. Lettieri and H. L. Fung. Dose-dependent pharmacokinetics and hypnotic effects of sodium gamma-hydroxybutyrate in the rat. J. Pharmacol. Exp. Ther. 208:7–11 (1979).
S. D. Ferrara, S. Zotti, L. Tedeschi, G. Frison, F. Castagna, L. Gallimberti, G. L. Gessa, and P. Palatini. Pharmacokinetics of gamma-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses. Br. J. Clin. Pharmacol. 34:231–235 (1992).
P. Palatini, L. Tedeschi, G. Frison, R. Padrini, R. Zordan, R. Orlando, L. Gallimberti, G. L. Gessa, and S. D. Ferrara. Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers. Eur. J. Clin. Pharmacol. 45:353–356 (1993).
S. D. Ferrara, L. Tedeschi, G. Frison, R. Orlando, M. Mazzo, R. Zordan, R. Padrini, and P. Palatini. Effect of moderate or severe liver dysfunction on the pharmacokinetics of gamma-hydroxybutyric acid. Eur. J. Clin. Pharmacol. 50:305–310 (1996).
M. B. Scharf, A. A. Lai, B. Branigan, R. Stover, and D. B. Berkowitz. Pharmacokinetics of gammahydroxybutyrate (GHB) in narcoleptic patients. Sleep 21:507–514 (1998).
J. Lettieri and H. L. Fung. Absorption and first-pass metabolism of 14C-gamma-hydroxybutyric acid. Res. Commun. Chem. Pathol. Pharmacol. 13:425–437 (1976).
C. Arena and H. L. Fung. Absorption of sodium gamma-hydroxybutyrate and its prodrug gamma-butyrolactone: relationship between in vitro transport and in vivo absorption. J. Pharm. Sci. 69:356–358 (1980).
M. E. Morris, K. Hu, and Q. Wang. Renal clearance of gamma-hydroxybutyric acid in rats: increasing renal elimination as a detoxification strategy. J. Pharmacol. Exp. Ther. 313:1194–1202 (2005).
A. P. Halestrap and D. Meredith. The SLC16 gene family—from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflugers Arch. 447:619–628 (2004).
A. P. Halestrap and N. T. Price. The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem. J. 343(Pt 2):281–299 (1999).
R. Y. Lin, J. C. Vera, R. S. Chaganti, and D. W. Golde. Human monocarboxylate transporter 2 (MCT2) is a high affinity pyruvate transporter. J. Biol. Chem. 273:28959–28965 (1998).
C. K. Garcia, J. L. Goldstein, R. K. Pathak, R. G. Anderson, and M. S. Brown. Molecular characterization of a membrane transporter for lactate, pyruvate, and other monocarboxylates: implications for the Cori cycle. Cell 76:865–873 (1994).
C. Hadjiagapiou, L. Schmidt, P. K. Dudeja, T. J. Layden, and K. Ramaswamy. Mechanism(s) of butyrate transport in Caco-2 cells: role of monocarboxylate transporter 1. Am. J. Physiol.: Gastrointest. Liver Physiol. 279:G775–G780 (2000).
I. Tamai, Y. Sai, A. Ono, Y. Kido, H. Yabuuchi, H. Takanaga, E. Satoh, T. Ogihara, O. Amano, S. Izeki, and A. Tsuji. Immunohistochemical and functional characterization of pH-dependent intestinal absorption of weak organic acids by the monocarboxylic acid transporter MCT1. J. Pharm. Pharmacol. 51:1113–1121 (1999).
A. Okamura, A. Emoto, N. Koyabu, H. Ohtani, and Y. Sawada. Transport and uptake of nateglinide in Caco-2 cells and its inhibitory effect on human monocarboxylate transporter MCT1. Br. J. Pharmacol. 137:391–399 (2002).
S. A. Tsuji A, I. Tamai, and T. Terasaki. Transport mechanism of 3-hydroxy-3-methylglutaryl conenzyme A reductase inhibitors at the blood–brain barrier. J. Pharmacol. Exp. Ther. 267:1085–1090 (1993).
K. Nagasawa, K. Nagai, Y. Sumitani, Y. Moriya, Y. Muraki, K. Takara, N. Ohnishi, T. Yokoyama, and S. Fujimoto. Monocarboxylate transporter mediates uptake of lovastatin acid in rat cultured mesangial cells. J. Pharm. Sci. 91:2605–2613 (2002).
M. J. Ryan, G. Johnson, J. Kirk, S. M. Fuerstenberg, R. A. Zager, and B. Torok-Storb. HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int. 45:48–57 (1994).
A. Bhandari, S. Koul, A. Sekhon, S. K. Pramanik, L. S. Chaturvedi, M. Huang, M. Menon, and H. K. Koul. Effects of oxalate on HK-2 cells, a line of proximal tubular epithelial cells from normal human kidney. J. Urol. 168:253–259 (2002).
J. C. Whitin, S. Bhamre, D. M. Tham, and H. J. Cohen. Extracellular glutathione peroxidase is secreted basolaterally by human renal proximal tubule cells. Am. J. Physiol. Renal Physiol. 283:F20–F28 (2002).
N. Romiti, G. Tramonti, and E. Chieli. Influence of different chemicals on MDR-1 P-glycoprotein expression and activity in the HK-2 proximal tubular cell line. Toxicol. Appl. Pharmacol. 183:83–91 (2002).
N. Romiti, G. Tramonti, A. Donati, and E. Chieli. Effects of grapefruit juice on the multidrug transporter P-glycoprotein in the human proximal tubular cell line HK-2. Life Sci. 76:293–302 (2004).
K. Balamurugan, N. D. Vaziri, and H. M. Said. Biotin uptake by human proximal tubular epithelial cells: cellular and molecular aspects. Am. J. Physiol. Renal Physiol. 288:F823–F831 (2005).
Q. Wang, Y. Lu, M. Yuan, I. Darling, E. Repasky, and M. Morris. Characterization of monocarboxylate transport in human kidney HK-2 Cells. Mol. Pharmacol. 3:675–685 (2006).
D. Kim, S. H. Garrett, M. A. Sens, S. Somji, and D. A. Sens. Metallothionein isoform 3 and proximal tubule vectorial active transport. Kidney Int. 61:464–472 (2002).
S. Zhang and M. Morris. Effect of the flavonoids biochanin A and silymarin on the P-glycoprotein-mediated transport of digoxin and vinblastine in human intestinal Caco-2 cells. Pharm. Res. 20:1184–1191 (2003).
D. Eladari, R. Chambrey, T. Irinopoulou, F. Leviel, F. Pezy, P. Bruneval, M. Paillard, and R. A. Podevin. Polarized expression of different monocarboxylate transporters in rat medullary thick limbs of Henle. J. Biol. Chem. 274:28420–28426 (1999).
N. T. Price, V. N. Jackson, and A. P. Halestrap. Cloning and sequencing of four new mammalian monocarboxylate transporter (MCT) homologues confirms the existence of a transporter family with an ancient past. Biochem. J. 329(Pt 2):321–328 (1998).
M. J. Coady, M.-H. Chang, F. M. Charron, C. Plata, B. Wallendorff, J. F. Sah, S. D. Markowitz, M. F. Romero, and J.-Y. Lapointe. The human tumour suppressor gene SLC5A8 expresses a Na+-monocarboxylate cotransporter. J. Physiol. 557:719–731 (2004).
L. Carpenter and A. P. Halestrap. The kinetics, substrate and inhibitor specificity of the lactate transporter of Ehrlich–Lettre tumour cells studied with the intracellular pH indicator BCECF. Biochem. J. 304(Pt 3):751–760 (1994).
J. E. Manning Fox, D. Meredith, and A. P. Halestrap. Characterisation of human monocarboxylate transporter 4 substantiates its role in lactic acid efflux from skeletal muscle. J. Physiol. 529(Pt 2):285–293 (2000).
E. F. Grollman, N. J. Phlip, P. McPhie, R. D. Ward, and B. Sauer. Determination of transport kinetics of Chick MCT3 monocarboxylate transporter from retinal pigment epithelium by expression in genetically modified yeast. Biochemistry 39:9351–9357 (2000).
S. Broer, A. Broer, H. P. Schneider, C. Stegen, A. P. Halestrap, and J. W. Deitmer. Characterization of the high-affinity monocarboxylate transporter MCT2 in Xenopus laevis oocytes. Biochem. J. 341(Pt 3):529–535 (1999).
Q. Wang, I. M. Darling, and M. E. Morris. Transport of gamma-hydroxybutyrate in rat kidney membrane vesicles—Role of monocarboxylate transporters. J. Pharmacol. Exp. Ther. 318:751–761 (2006).
H. Li, L. Myeroff, D. Smiraglia, M. F. Romero, T. P. Pretlow, L. Kasturi, J. Lutterbaugh, R. M. Rerko, G. Casey, J. P. Issa, J. Willis, J. K. Willson, C. Plass, and S. D. Markowitz. SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers. Proc. Natl. Acad. Sci. U.S.A. 100:8412–8417 (2003).
Acknowledgments
Support was provided by NIH grant DA14988, by a grant from the Western New York Kidney Foundation/Upstate New York Transplant Service and by a Mark-Diamond grant from University at Buffalo.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, Q., Lu, Y. & Morris, M.E. Monocarboxylate Transporter (MCT) Mediates the Transport of γ-Hydroxybutyrate in Human Kidney HK-2 cells. Pharm Res 24, 1067–1078 (2007). https://doi.org/10.1007/s11095-006-9228-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-006-9228-6